Evidence map›Paper›PMID 28429110›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2017

Inhibition of the CRF

Andrzej Wróbel, Anna Serefko, Aleksandra Szopa, Karol Rojek, Ewa Poleszak, Krystyna Skalicka-Woźniak, Jarosław Dudka

Open access · hybridAbstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andrzej WróbelSecond Department of Gynecology, Medical University of Lublin, Jaczewskiego 8, 20-090, Lublin, Poland.
Anna SerefkoChair and Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland. anna.serefko@umlub.pl.ORCID http://orcid.org/0000-0002-5732-8950
Aleksandra SzopaChair and Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland.
Karol RojekChair and Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland.
Ewa PoleszakChair and Department of Applied Pharmacy, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland.
Krystyna Skalicka-WoźniakDepartment of Pharmacognosy with Medicinal Plants Unit, Medical University of Lublin, Chodźki 1, 20-093, Lublin, Poland.
Jarosław DudkaDepartment of Toxicology, Medical University of Lublin, Jaczewskiego 8B, 20-093, Lublin, Poland.
Medical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperactivity of the hypothalamic-pituitary-adrenal axis (HPA) and impairment of the central corticotropin-releasing factor (CRF) system are factors in the pathogenesis of depression. Though several antagonists of the CRF

Indexed as

AmygdalaAnimalsAntidepressive AgentsBehavior, AnimalCorticosteroneCorticotropin-Releasing HormoneCRF Receptor, Type 1DepressionDrug Therapy, CombinationFemaleFluoxetineHypothalamusImipramineLocomotionPyridinesRats, WistarAntidepressive AgentsCorticosteroneCorticotropin-Releasing HormoneCRF Receptor, Type 1FluoxetineImipraminePyridinesReceptors, Corticotropin-Releasing HormoneSN003TriazolesCorticotropin-releasing factor levelCRF1 receptor antagonistFluoxetineForced swim testImipramineRats

Identifiers

PMID28429110
PMCPMC5509780
OpenAlexW2607089098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.